Completed PHASE3 NCT00105404

Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation

A Randomized Trial Comparing Intravitreal Triamcinolone Acetonide and Laser Photocoagulation for Diabetic Macular Edema

Sponsor: National Eye Institute (NEI)

Conditions DME Diabetic Macular Edema Diabetic Retinopathy

Updated 5 times since 2017 Last updated: Jun 30, 2017 Started: Mar 9, 2005 Completion: Oct 30, 2006

Listed as NCT00105404, this PHASE3 trial focuses on DME and Diabetic Macular Edema and remains completed. Sponsored by National Eye Institute (NEI), it has been updated 5 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Mar 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Eye Institute (NEI)

Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bethesda, United States